Lumexa Imaging Inc. Common Stock
LMRI | NASDAQ
$11.14
-$0.27 (-2.37%)
Nov 2, 2026, 12:13 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 |
|---|---|---|---|---|---|---|
Revenue | 1.04B | 779.22M | 771.68M | 751.97M | 493.03M | 248.03M |
Cost of Revenue | 920.29M | 684.93M | 665.65M | 654.09M | 434.85M | 226.46M |
Gross Profit | 123.08M | 94.29M | 106.03M | 97.88M | 58.18M | 21.57M |
Operating Income | 14.43M | 10.03M | 15.56M | 38.29M | 25.31M | 15.25M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -16.65M | -22.41M | -29.8M | -20.57M | -20.33M | -16.03M |
Net Income | -27.73M | -30.47M | -39.88M | -36.25M | -32.75M | -25.06M |
Selling & General & Admin | 99M | 74.61M | 71.76M | 54.69M | 37.61M | 20.12M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 9.65M | 9.65M | 18.71M | 4.91M | -4.75M | -13.8M |
Operating Expenses | 108.66M | 84.26M | 90.47M | 59.6M | 32.86M | 6.32M |
Interest Expense | 91.15M | 74.92M | 88.44M | 91.81M | 61.24M | 31.39M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.03B | 769.19M | 756.12M | 713.69M | 467.72M | 232.78M |
Income Tax Expense | 11.08M | 8.06M | 10.08M | 15.68M | 12.41M | 9.03M |
Shares Outstanding (Basic) | 95.98M | 95.98M | 75.35M | 82.77M | 94.57M | 94.57M |
Shares Outstanding (Diluted) | 96.01M | 95.98M | 75.35M | 82.77M | 94.57M | 94.57M |
EPS (Basic) | -0.38 | -0.40 | -0.50 | -0.38 | -0.34 | -0.26 |
EPS (Diluted) | -0.38 | -0.40 | -0.50 | -0.38 | -0.34 | -0.26 |
EBITDA | 111.42M | 92.34M | 97.22M | 111M | 67.27M | 28.94M |
EBIT | 56.91M | 52.51M | 58.64M | 71.24M | 40.9M | 15.36M |
Depreciation & Amortization | 54.51M | 39.83M | 38.58M | 39.76M | 26.37M | 13.58M |
Add to Watchlist
Select watchlists to add or remove LMRI